These constraints in the BTNX NTS are highly suitable, as we located e.g. etodesnitazene to acquire a similar in vitro potency and efficacy as fentanyl [7, 13] and as it may most likely give PWUD a Bogus perception of basic safety. Furthermore, the detectability of nitazene analogues in drug samples could be impacted by solubility difficulties, as